Morning Market Movers By: Benzinga via Benzinga April 10, 2014 at 09:42 AM EDT Celladon (NASDAQ: CLDN) rose 25.73% to $13.39 after the company received a breakthrough therapy designation from the FDA for MYDICAR. ... Read More >> Related Stocks: Automatic Data Processing Aveo Pharmaceuticals Pier 1 Imports Rite Aid Corp Titan Machinery Inc